A Word From our Experts
Our Thoughts on the Drug Supply Chain, Communicatoin, and DSCSA
The Drug Manufacturer’s DSCSA Dilemma
A decade’s worth of time has expired since the Drug Supply Chain Security Act (DSCSA) was passed to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. This November marks the start of the 12 month countdown requiring pharmaceutical trading partners to comply with the law. As time quickly slips away, trading partners are still left with unanswered questions and serious operational risks if found to be non-compliant by November 27, 2023.
Read MoreResolvers: The Internet’s Address Book
What exactly does it mean when someone says they have configured a “resolver?” This quick post will explain the concept of a resolver, how Trust.med is using resolvers to address DSCSA compliance, and how you can start using resolvers today…
Read MoreAll for One, One for All: Interoperable Ecosystems for DSCSA
The industry will need the ability to collaborate with each other and connect to relevant distributed data sets within an interoperable ecosystem by November 2023…
Read MoreSharing Should Be Easy: Have You Achieved Interoperability for DSCSA Compliance?
Interoperability is a characteristic of an ability to work with others. DSCSA requires that ATPs be able to work among themselves to exchange product information as needed for the purpose of transaction, product verification or trace for various suspect/illegitimate product reasons, and for enhancement of industry recall mechanisms…
Read More- « Previous
- 1
- 2